BioPhase 8800 Capillary Electrophoresis System
Existing approaches to detect and characterize changes during development of monoclonal antibodies (mAbs), next-generation therapeutics, and gene therapies are challenged to deliver the detailed information you need, in the time you need it.
The SCIEX BioPhase 8800 is a multi-capillary electrophoresis system that enables biopharma scientists to run multiple samples in parallel, accelerating the development and execution of sensitive, high-throughput analytical methods. The increased throughput and reproducibility of the system minimizes bottlenecks in the drug development pipeline, helping shorten time to market. Innovated from the ground up, the SCIEX BioPhase 8800 helps biopharmaceutical labs take charge of their development pipelines. Scientists can now assess molecular liabilities more quickly, allowing rapid developability assessment to streamline the selection of candidates to be progressed into an effective therapy.
The SCIEX BioPhase 8800 system facilitates parallel processing of eight samples simultaneously, while retaining the capability to deliver sensitive CE-SDS, and CIEF analysis enabling uncompromised accuracy for large sample sets and faster time to answers. Delivering consistent, comparable and compliant data at scale across the biologic development continuum, the SCIEX BioPhase 8800 provides high-throughput, high sensitivity analysis for bioprocessing, analytical development and QA/QC, all in one system.
CE-SDS
The BioPhase 8800 system provides automated, quantitative and repeatable capillary electrophoresis sodium dodecyl sulfate (CE-SDS) separations, delivering high resolution purity analysis to help you keep pace with workloads while also minimizing sample prep and processing time.
CIEF Analysis
The BioPhase 8800 system delivers rapid and reproducible charge heterogeneity analysis via multi-capillary isoelectric focusing. Parallel processing of 8 samples simultaneously allows for significant improvements in method development and optimization time.
